Yiming Xu

1.8k total citations · 1 hit paper
49 papers, 1.4k citations indexed

About

Yiming Xu is a scholar working on Molecular Biology, Organic Chemistry and Biological Psychiatry. According to data from OpenAlex, Yiming Xu has authored 49 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 19 papers in Organic Chemistry and 6 papers in Biological Psychiatry. Recurrent topics in Yiming Xu's work include Inflammasome and immune disorders (12 papers), Carbohydrate Chemistry and Synthesis (6 papers) and Synthesis of heterocyclic compounds (6 papers). Yiming Xu is often cited by papers focused on Inflammasome and immune disorders (12 papers), Carbohydrate Chemistry and Synthesis (6 papers) and Synthesis of heterocyclic compounds (6 papers). Yiming Xu collaborates with scholars based in China, United States and Pakistan. Yiming Xu's co-authors include Shijun Zhang, Hallie Blevins, Savannah Biby, Lisheng Wang, Haroon Ur Rashid, Yaseen Muhammad, Wei‐Shan Zhou, Jun Jiang, Nasir Ahmad and Lixin Liao and has published in prestigious journals such as The FASEB Journal, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Yiming Xu

49 papers receiving 1.4k citations

Hit Papers

The NLRP3 Inflammasome Pa... 2022 2026 2023 2024 2022 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yiming Xu China 17 634 627 130 120 78 49 1.4k
Hwayoung Yun South Korea 20 686 1.1× 382 0.6× 206 1.6× 101 0.8× 39 0.5× 80 1.8k
Xiangbao Meng China 25 986 1.6× 877 1.4× 205 1.6× 107 0.9× 69 0.9× 103 2.1k
Huibin Zhang China 23 774 1.2× 464 0.7× 166 1.3× 77 0.6× 22 0.3× 91 1.6k
Jian-Shu Lou China 22 864 1.4× 178 0.3× 126 1.0× 138 1.1× 47 0.6× 51 1.6k
Jinpei Zhou China 22 745 1.2× 474 0.8× 148 1.1× 80 0.7× 20 0.3× 90 1.4k
Xiang‐Yang Ye China 25 1.1k 1.7× 711 1.1× 104 0.8× 342 2.9× 66 0.8× 79 2.4k
Fabrício Figueiró Brazil 26 755 1.2× 225 0.4× 295 2.3× 122 1.0× 20 0.3× 81 1.9k
Yuepiao Cai China 25 827 1.3× 351 0.6× 203 1.6× 174 1.4× 13 0.2× 66 1.7k

Countries citing papers authored by Yiming Xu

Since Specialization
Citations

This map shows the geographic impact of Yiming Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiming Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiming Xu more than expected).

Fields of papers citing papers by Yiming Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiming Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiming Xu. The network helps show where Yiming Xu may publish in the future.

Co-authorship network of co-authors of Yiming Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yiming Xu. A scholar is included among the top collaborators of Yiming Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiming Xu. Yiming Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, L., Yiming Xu, Xinghai Li, Peng Cheng, & Shengyang Tao. (2025). Production and evaluation of high-throughput reaction data from an automated chemical synthesis platform. Science China Chemistry. 68(10). 5322–5331. 1 indexed citations
3.
Xu, Yiming, Savannah Biby, Chunqing Guo, et al.. (2024). Characterization of a small molecule inhibitor of the NLRP3 inflammasome and its potential use for acute lung injury. Bioorganic Chemistry. 150. 107562–107562. 3 indexed citations
4.
Xu, Yiming, et al.. (2023). Development of NLRP3 PET Radiotracers for Alzheimer’s disease. Alzheimer s & Dementia. 19(S17). 1 indexed citations
5.
Xu, Yiming, Yulong Xu, Savannah Biby, et al.. (2023). Design and Discovery of Novel NLRP3 Inhibitors and PET Imaging Radiotracers Based on a 1,2,3-Triazole-Bearing Scaffold. Journal of Medicinal Chemistry. 67(1). 555–571. 7 indexed citations
6.
Xu, Yiming, Yulong Xu, Hallie Blevins, et al.. (2022). Development of sulfonamide-based NLRP3 inhibitors: Further modifications and optimization through structure-activity relationship studies. European Journal of Medicinal Chemistry. 238. 114468–114468. 17 indexed citations
7.
Zhao, Dong, Yiming Xu, Feng Yu, et al.. (2021). Complex Crystal Structure Determination and in vitro Anti–non–small Cell Lung Cancer Activity of Hsp90N Inhibitor SNX-2112. Frontiers in Cell and Developmental Biology. 9. 650106–650106. 9 indexed citations
8.
Jiang, Yuqi, et al.. (2021). Structural understanding of 5-(4-hydroxy-phenyl)-N-(2-(5-methoxy-1H-indol-3-yl)-ethyl)-3-oxopentanamide as a neuroprotectant for Alzheimer’s disease. Bioorganic & Medicinal Chemistry Letters. 43. 128081–128081. 2 indexed citations
9.
Kuwar, Ram, Andrew Rolfe, Hallie Blevins, et al.. (2021). A Novel Inhibitor Targeting NLRP3 Inflammasome Reduces Neuropathology and Improves Cognitive Function in Alzheimer’s Disease Transgenic Mice. Journal of Alzheimer s Disease. 82(4). 1769–1783. 62 indexed citations
10.
Rashid, Haroon Ur, Yiming Xu, Yaseen Muhammad, Lisheng Wang, & Jun Jiang. (2018). Research advances on anticancer activities of matrine and its derivatives: An updated overview. European Journal of Medicinal Chemistry. 161. 205–238. 159 indexed citations
11.
Xu, Yiming, Lichuan Wu, Haroon Ur Rashid, et al.. (2018). Novel indolo-sophoridinic scaffold as Topo I inhibitors: Design, synthesis and biological evaluation as anticancer agents. European Journal of Medicinal Chemistry. 156. 479–492. 13 indexed citations
12.
Xu, Yiming, Rui Chen, Haroon Ur Rashid, et al.. (2018). Design, synthesis and evaluation of novel sophoridinic imine derivatives containing conjugated planar structure as potent anticancer agents. Bioorganic & Medicinal Chemistry. 26(14). 4136–4144. 15 indexed citations
13.
Xu, Yiming, Lichuan Wu, Mingyan Gao, et al.. (2017). Novel α, β-Unsaturated Sophoridinic Derivatives: Design, Synthesis, Molecular Docking and Anti-Cancer Activities. Molecules. 22(11). 1967–1967. 13 indexed citations
14.
Xu, Yiming, Eugenia Aldeco‐Pérez, H. Rudler, Andrée Parlier, & Cecilio Álvarez. (2006). Selective functionalizations of 2-phenylpyridine: lactones upon organic versus organometallic activations. Tetrahedron Letters. 47(27). 4553–4556. 13 indexed citations
15.
Rudler, H., Bernard Denise, Yiming Xu, & Jacqueline Vaissermann. (2005). Double nucleophilic addition of bis(trimethylsilyl)ketene acetals to carbon–carbon double bonds of pyrazines: formation of polycyclic γ-lactones. Tetrahedron Letters. 46(20). 3449–3451. 13 indexed citations
16.
Xu, Yiming, Seok-Rye Choi, Mei‐Ping Kung, & Hank F. Kung. (1999). Synthesis of radioiodinated 1-deoxy-nojirimycin derivatives: novel glucose analogs. Nuclear Medicine and Biology. 26(7). 833–839. 9 indexed citations
17.
Zhou, Wei‐Shan, et al.. (1999). Synthesis of optically active α-furfuryl amine derivatives and application to the asymmetric syntheses. Tetrahedron. 55(41). 11959–11983. 41 indexed citations
18.
Liao, Lixin, et al.. (1999). New concise asymmetric total synthesis of (+)-desoxoprosophylline and prosophylline. Tetrahedron Asymmetry. 10(12). 2311–2318. 31 indexed citations
19.
Xu, Yiming & Wen Zhou. (1996). ChemInform Abstract: A New Approach to 1‐Deoxyazasugars: Asymmetric Synthesis of Deoxymannojirimycin.. ChemInform. 27(24). 1 indexed citations
20.
Xu, Yiming, et al.. (1991). PHOTOCATALYTIC DEGRADATION OF PHENOL AND CHLOROPHENOLS ON Pt/TiO2-COATED PHOTOREACTOR. Chinese Journal of Applied Chemistry. 8(6). 28–32. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026